- Home
- LITB vs CRIS Comparison
LITB vs CRIS Comparison
Compare LITB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LITB | CRIS |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1M | 20.6M |
| IPO Year | 2013 | 2000 |
Fundamental Metrics
Financial Performance| Metric | LITB | CRIS |
|---|---|---|
| Price | $3.02 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 5.6K | ★ 122.2K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | $14.50 | $27.10 |
| Revenue Next Year | $11.59 | $67.74 |
| P/E Ratio | $10.96 | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $1.63 | $0.18 |
| 52 Week High | $4.17 | $6.74 |
Technical Indicators
Market Signals| Indicator | LITB | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 22.04 |
| Support Level | $2.82 | $0.95 |
| Resistance Level | $3.34 | $1.21 |
| Average True Range (ATR) | 0.15 | 0.10 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 39.34 | 6.25 |
Price Performance
Historical ComparisonAbout LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.